About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cd4tm1(cre/ERT2)Thbu
targeted mutation 1, Thorsten Buch
MGI:5549971
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Cd4tm1(cre/ERT2)Thbu/Cd4+
Tgfbr2tm1Karl/Tgfbr2tm1Karl
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5550067
cn2
Cd4tm1(cre/ERT2)Thbu/Cd4+
Gfm1tm1c(EUCOMM)Wtsi/Gfm1tm1c(EUCOMM)Wtsi
involves: C57BL/6 * C57BL/6N * SJL MGI:6508531


Genotype
MGI:5550067
cn1
Allelic
Composition
Cd4tm1(cre/ERT2)Thbu/Cd4+
Tgfbr2tm1Karl/Tgfbr2tm1Karl
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd4tm1(cre/ERT2)Thbu mutation (0 available); any Cd4 mutation (85 available)
Tgfbr2tm1Karl mutation (1 available); any Tgfbr2 mutation (40 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
N
• after 5 days of tamoxifen treatment, mice display no weight loss and appeared healthy at 2 and 4 weeks post-tamoxifen; no overt phenotype is observed 3 months following 2 months of tamoxifen treatment

immune system
N
• no cellular infiltrates (suggesting autoimmune responses) are detected in organs including liver, kidney, pancreas, heart, colon and thyroid gland from animals that received tamoxifen treatment
• no secondary effects on B cell tolerance indicated by autoantibody production are seen in mice at 6 weeks or 5 months after tamoxifen treatment
• at 2 and 4 weeks after tamoxifen treatment, mice show a modest but significant transient expansion of effector memory T cells in the spleen and lymph nodes; numbers and frequency of effector memory cells return to control levels at 6 weeks after tamoxifen administration as result of replacement with new T cells
• proliferation of effector memory T cells is increased without similar increase observed for naive T cells or central memory CD4+ T cells
• in mice thymectomized prior to tamoxifen treatment, elevation of effector memory T cells persists in absence of thymic emigration
• hyperproliferation of regulatory T cells is observed at 2 an 4 weeks after tamoxifen treatment; increased numbers are observed in lymph nodes, the spleen, the lung and Peyer's patches, but not in intestinal lamina propria

hematopoietic system
• at 2 and 4 weeks after tamoxifen treatment, mice show a modest but significant transient expansion of effector memory T cells in the spleen and lymph nodes; numbers and frequency of effector memory cells return to control levels at 6 weeks after tamoxifen administration as result of replacement with new T cells
• proliferation of effector memory T cells is increased without similar increase observed for naive T cells or central memory CD4+ T cells
• in mice thymectomized prior to tamoxifen treatment, elevation of effector memory T cells persists in absence of thymic emigration
• hyperproliferation of regulatory T cells is observed at 2 an 4 weeks after tamoxifen treatment; increased numbers are observed in lymph nodes, the spleen, the lung and Peyer's patches, but not in intestinal lamina propria




Genotype
MGI:6508531
cn2
Allelic
Composition
Cd4tm1(cre/ERT2)Thbu/Cd4+
Gfm1tm1c(EUCOMM)Wtsi/Gfm1tm1c(EUCOMM)Wtsi
Genetic
Background
involves: C57BL/6 * C57BL/6N * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd4tm1(cre/ERT2)Thbu mutation (0 available); any Cd4 mutation (85 available)
Gfm1tm1c(EUCOMM)Wtsi mutation (0 available); any Gfm1 mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• differentiation of tamoxifen-treated nave T cells under Th17 cell-skewing conditions yields a reduced frequency of IL-17 expressing cells
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus
• tamoxifen-treated mice show significant protection from the development of experimental autoimmune encephalomyelitis (EAE), with mice showing lower numbers and percentages of MOG-specific IL-17 and IFN-gamma-producing Th cells in the central nervous system

hematopoietic system
• differentiation of tamoxifen-treated nave T cells under Th17 cell-skewing conditions yields a reduced frequency of IL-17 expressing cells
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory